The pregnancy-related decrease in fasting plasma homocysteine is not explained by folic acid supplementation, hemodilution, or a decrease in albumin in a longitudinal study

被引:112
作者
Murphy, MM
Scott, JM
McPartlin, JM
Fernandez-Ballart, JD
机构
[1] Univ Rovira & Virgili, Unit Med Prevent, Fac Med, E-43201 Reus, Spain
[2] Trinity Coll Dublin, Dept Biochem, Dublin, Ireland
[3] St James Hosp, Vitamin Res Unit, Sir Patrick Dunns Res Lab, Dublin 8, Ireland
关键词
homocysteine; pregnancy; preconception; folic acid; supplementation; albumin; hematocrit; longitudinal study;
D O I
10.1093/ajcn/76.3.614
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 [营养与食品卫生学];
摘要
Background: Fasting plasma total homocysteine (tHcy) decreases during pregnancy. Previous reports suggested that this is due to folic acid supplementation, hemodilution, or a decrease in albumin. However, these hypotheses have not been tested in a longitudinal study. Objective: We investigated the relation between pregnancy-related physiologic changes and tHcy in a group of healthy women who were either unsupplemented or supplemented with folic acid. Design: In a longitudinal study from preconception throughout pregnancy, we studied 54 unsupplemented women and 39 women who were supplemented with folic acid during the second or third trimester of pregnancy. tHcy, hematocrit, and serum albumin were determined preconceptionally and at 8, 20, and 32 wk of pregnancy. Results: For the entire group, geometric mean tHcy concentrations at preconception (8.2 mumol/L) were significantly greater (P < 0.001) than those at 8 wk of pregnancy (6.4 mumol/L). When the unsupplemented and supplemented groups were regarded separately, geometric mean tHcy concentrations at preconception were significantly greater than those at 20 (5.22 and 4.18 mumol/L, respectively) and 32 (5.16 and 4.42 mumol/L, respectively) wk of pregnancy (P < 0.001 for both). Mean reductions from preconception concentrations at 8, 20, and 32 wk of pregnancy were significantly greater (P < 0.001) for tHcy (-11.5%, -25.5%, and -24.5%, respectively) than for hematocrit (-1.9%, -4.2%, and -4.3%, respectively) or serum albumin (-1.1%, -9.8%, and -13.4%, respectively). There was no correlation between changes in either hematocrit or serum albumin and changes in tHcy. Conclusions: This study refutes the previous explanations for the reduction in plasma tHcy known to occur in pregnancy, namely, folic acid supplementation, hemodilution, and a decrease in serum albumin. We suggest that the changes may be endocrine-based.
引用
收藏
页码:614 / 619
页数:6
相关论文
共 22 条
[1]
ANDERSSON A, 1992, EUR J CLIN CHEM CLIN, V30, P377
[2]
Longitudinal vitamin and homocysteine levels in normal pregnancy [J].
Cikot, RJLM ;
Steegers-Theunissen, RPM ;
Thomas, CMG ;
de Boo, TM ;
Merkus, HMWM ;
Steegers, EAP .
BRITISH JOURNAL OF NUTRITION, 2001, 85 (01) :49-58
[3]
CRUIKSHANK DP, 1996, OBSTET NORMAL PROBLE, P91
[4]
Vitamin supplementation reduces blood homocysteine levels - A controlled trial in patients with venous thrombosis and healthy volunteers [J].
den Heijer, M ;
Brouwer, IA ;
Bos, GMJ ;
Blom, HJ ;
van der Put, NMJ ;
Spaans, AP ;
Rosendaal, FR ;
Thomas, CMG ;
Haak, HL ;
Wijermans, PW ;
Gerrits, WBJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (03) :356-361
[5]
Oral estrogen improves serum lipids, homocysteine and fibrinolysis in elderly men [J].
Giri, S ;
Thompson, PD ;
Taxel, P ;
Contois, JH ;
Otvos, J ;
Allen, R ;
Ens, G ;
Wu, AHB ;
Waters, DD .
ATHEROSCLEROSIS, 1998, 137 (02) :359-366
[6]
Hyperhomocysteinemia: A risk factor for placental abruption or infarction [J].
GoddijnWessel, TAW ;
Wouters, MGAJ ;
VanderMolen, EF ;
Spuijbroek, MDEH ;
SteegersTheunissen, RPM ;
Blom, HJ ;
Boers, GHJ ;
Eskes, TKAB .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1996, 66 (01) :23-29
[7]
*I STAT CAT, 1996, POP CENS MUN REC INH
[8]
TOTAL HOMOCYST(E)INE IN PLASMA AND AMNIOTIC-FLUID OF PREGNANT-WOMEN [J].
KANG, SS ;
WONG, PWK ;
ZHOU, J ;
COOK, HY .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1986, 35 (10) :889-891
[9]
Cortisol and estradiol: Nongenetic factors for hyperhomocyst(e)inemia [J].
Kim, MH ;
Kim, E ;
Passen, EL ;
Meyer, J ;
Kang, SS .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1997, 46 (03) :247-249
[10]
Malinow MR, 1998, AM J OBSTET GYNECOL, V178, P228